Cargando…
Insulin and insulin-like growth factor prevent brain atrophy and cognitive impairment in diabetic rats
There are an estimated 36 million dementia patients worldwide. The anticipated tripling of this number by year 2050 will negatively impact the capacity to deliver quality health care. The epidemic in diabetes is particularly troubling, because diabetes is a substantial risk factor for dementia indep...
Autores principales: | Šerbedžija, Predrag, Ishii, Douglas N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602990/ https://www.ncbi.nlm.nih.gov/pubmed/23565496 http://dx.doi.org/10.4103/2230-8210.105578 |
Ejemplares similares
-
Insulin-Like Growth Factor Replacement Therapy for Diabetic Neuropathy: Experimental Basis
por: Ishii, Douglas N., et al.
Publicado: (2003) -
Doxorubicin Impairs the Insulin-Like Growth Factor-1 System and Causes Insulin-Like Growth Factor-1 Resistance in Cardiomyocytes
por: Fabbi, Patrizia, et al.
Publicado: (2015) -
Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington’s Disease
por: Salem, Linda, et al.
Publicado: (2016) -
Little effects of Insulin-like Growth Factor-I on testicular atrophy induced by hypoxia
por: Diez-Caballero, Fernando, et al.
Publicado: (2006) -
The Role of Insulin and Insulin-like Growth Factors in the Increased Risk
of Cancer in Diabetes
por: LeRoith, Derek, et al.
Publicado: (2011)